Lv1
24 积分 2024-05-15 加入
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
13小时前
待确认
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
18小时前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
1天前
已完结
Phase I/II Study of Dasatinib and Exploratory Genomic Analysis in Relapsed or Refractory Non-Hodgkin Lymphoma
4天前
已完结
Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma
7天前
已完结
Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid Malignancies
8天前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
8天前
已完结
Twenty years in metalloprotein bioinformatics: A short history of a long journey
27天前
已完结
The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta‐analysis
1个月前
已完结
Long-read sequencing reveals oncogenic mechanism of HPV-human fusion transcripts in cervical cancer
1个月前
已完结
皖公网安备34019202002308
